Literature DB >> 22359164

Immunoglobulin production stimulating and inhibiting factors derived from human lung adenocarcinoma PC-8 cells : Ig production stimulating factor in PC-8 cells.

H Shinmoto1, H Murakami, K Yamada, S Dosako, H Omura.   

Abstract

Addition of a 3 M KCl extract of a human lung adenocarcinoma PC-8 cells to the culture media of lymphocytes, which were isolated from normal donors and from lung or breast cancer patients, elevated immunoglobulin (Ig) production by 3-5 times in the presence of pokeweed mitogen. However, addition of higher concentration of the extract inhibited Ig production and proliferation of lymphocytes. The Ig production stimulating factor (IPSF) was separated from the inhibiting factor, using 50% ammonium sulfate precipitation. Upon chromatofocusing, IPSF activity was detected mainly in the pH 4.5 fraction but minor activity was also detected in other pH fractions. IPSF also enhanced Ig production of a B-lymphoblastoid cell line transformed by Epstein-Barr virus and a human-human hybridoma, by more than 2-fold. This suggests that IPSF interacts with B-lymphocytes directly to enhance their Ig production. IPSF activity was also detected diversely in human lung squamous carcinoma QG56, human B-lymphoblastoid HO-323, and a T cell line CEM.

Entities:  

Year:  1988        PMID: 22359164     DOI: 10.1007/BF00365074

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

Review 1.  Suppressor cells: permitters and promoters of malignancy?

Authors:  D Naor
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

Review 2.  Cell-mediated immunity to tumor cells.

Authors:  R B Herberman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

3.  Isolation, characterization, and biological activities of five mitogens from pokeweed.

Authors:  M J Waxdal
Journal:  Biochemistry       Date:  1974-08-27       Impact factor: 3.162

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro.

Authors:  J Werkmeister; R Zbroja; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

6.  Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

Authors:  B M Vose; F Vánky; E Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

7.  Purification and biological activities of pokeweek (Phytolacca americana) mitogens.

Authors:  K Yokoyama; O Yano; T Terao; T Osawa
Journal:  Biochim Biophys Acta       Date:  1976-04-14

8.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

9.  Ia-bearing bone marrow-cultured macrophages induce antigen-specific helper T cells for antibody synthesis.

Authors:  A C Stern; P Erb; R H Gisler
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

10.  Transformation of human colostrum lymphocytes with Epstein-Barr virus and the production of IgA in culture.

Authors:  F Maeda-Takekoshi; M Takekoshi; S Tanaka; Y Watanabe; S Dosako; E Kikuchi
Journal:  Tokai J Exp Clin Med       Date:  1984-06
View more
  10 in total

1.  Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.

Authors:  T Sugahara; S Shirahata; K Yamada; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

2.  Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells.

Authors:  T Sugahara; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 3.  Physiological enhancement of immunoglobulin production of hybridomas in serum-free media.

Authors:  H Murakami; K Yamada; S Shirahata; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

4.  Purification and some properties of proliferation suppressing factor from human lung adenocarcinoma PC-8.

Authors:  H Shinmoto; S Dosako; K Yamada; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

5.  Stimulation of proliferation and immunoglobulin production of human-human hybridoma by various types of caseins and their protease digests.

Authors:  K Yamada; I Ikeda; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

6.  Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.

Authors:  M Yamaguchi; Y Shirai; Y Inouye; M Shoji; M Kamei; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

7.  Purification and characterization of lymphocytic clonal growth factor (LCGF) derived from human-human hybridoma SH-76 cells.

Authors:  M Miyata; H Murakami; S Hashizume; K Yamada; H Omura
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

8.  Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

Authors:  K Yamada; K Akiyoshi; H Murakami; T Sugahara; I Ikeda; K Toyoda; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

9.  Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions.

Authors:  K Yamada; I Ikeda; T Sugahara; S Hashizume; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

10.  Immunoglobulin production stimulating factor-II alpha (IPSF-II alpha) is glyceraldehyde-3-phosphate dehydrogenase like protein.

Authors:  T Sugahara; S Shirahata; K Akiyoshi; T Isobe; T Okuyama; H Murakami
Journal:  Cytotechnology       Date:  1991-06       Impact factor: 2.058

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.